Leukemia, Mast-Cell - 25 Studies Found
Completed |
: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant :
: |
Active, not recruiting |
: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer :
: |
Recruiting |
: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer :
: Other: cytology specimen collection procedure Correlative studies |
Completed |
: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy :
|
Terminated |
: Sunitinib in Treating Patients With Idiopathic Myelofibrosis :
: Drug: sunitinib malate Given PO |
Active, not recruiting |
: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer :
: |
Completed |
: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer :
: |
Active, not recruiting |
: Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies :
|
Active, not recruiting |
: Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer :
: |
Completed |
: Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) :
: 2007-06-26 : Drug: Ontak (Denileukin Diftitox) 9 µg/kg by vein Days 1-5 of a 21 day cycle. |